Role of stereotactic body radiation therapy for hepatocellular carcinoma

Figure 1 Dose distribution of stereotactic body radiation therapy for hepatocellular carcinoma at a dose of 40 Gy in 5 fractions, prescribed at the periphery of the target volume. The isodose lines (white solid lines) from inner to outer represent 40, 30, 20 and 10 Gy, respectively. The center of the tumor receives as high as 125% of the prescribed dose.